Guttmacher Institute: Medication Abortion
April 15, 2023
April 15, 2023
NEW YORK, April 15 -- The Guttmacher Institute, a research and policy organization that says it is committed to advancing sexual and reproductive health and rights worldwide, issued the following news release:
Laws and regulations on mifepristone are rapidly changing across the United States since the District Court for the Northern District of Texas ordered the Food and Drug Administration in April to revoke its approval of mifepristone, one of two pills used in medication abortion . . .
Laws and regulations on mifepristone are rapidly changing across the United States since the District Court for the Northern District of Texas ordered the Food and Drug Administration in April to revoke its approval of mifepristone, one of two pills used in medication abortion . . .